StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)

Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –

Anbio Biotechnology enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Anbio Biotechnology's enterprise value was $164.97M on Nov 11, 2026, against $979.12M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$164.97M-86.9%
2025Dec 31, 2025$1.26B–

More Anbio Biotechnology figures

See a number that looks wrong?